Sarantis Worldwide

Visit our group site

Sarantis Group| English

Or choose a location

Sarantis Group launches Bioten’s new antibacterial line for the hands

6 JULY 2020

Bioten, which belongs to Sarantis Group, one of the most popular and beloved brands of personal care, enriches its product portfolio with the new antibacterial line for the hands BIOTEN ANTIBACTERIAL, in order to meet the increased needs created due to the COVID 19 pandemic. The new line, which consists of Gel Lotion, combines antibacterial protection with the natural identity of the brand, has received the marketing license by the National Medicines Agency and will be available immediately.

Bioten holds leading positions in the categories it operates and counts 9 years of consumer preference, thanks to its products which are enriched with natural ingredients that offer effective care, with respect for the skin and the environment.

The brand’s personal care portfolio is enriched with a Gel and Hand Lotion with antibacterial action, in order to offer natural protection and care for your skin The lotion contains 80 v/v Εthanol of natural origin, while thanks to its light texture, it is absorbed immediately after application, without leaving any residue or sticky feeling It is available in a 100 ml bottle and in a 200 ml spray The Gel eliminates 99 9 of bacteria It is enriched with provitamin B 5 for skin care, while it has a light musk fragrance that leaves a pleasant feeling of cleanliness and freshness It is available in a 80 ml and 500 ml bottles with a practical pump packaging.

Sarantis Group, remaining faithful to its corporate responsible action, is committed to continue its efforts, through its brands, contributing to the promotion of the health, the quality of life and the environmental care.

Download in PDF (330.4KB)

Invitation to the Εxtraordinary General Shareholders' Meeting of December 20, 2023

The Board of Directors, in the context of implementing best Corporate Governance practices, has decided to further deepen the interaction with the shareholders and with the proxy advisors. In this direction and after consultation, the Board updated the recommendations on the items of the Extraordinary General Meeting and in order to provide the necessary preparation time to the shareholders, reconvenes an Extraordinary General Meeting on 20/12/2023.
Change cookies consent Revoke cookies consent